Skip to content

PEAK PHARMACEUTICALS, INC.

RMHI

CIK 0001452804

← back to feed
Revenue (TTM)
$0
Q1 Feb 2023
Net Income (TTM)
−$217.33K
−116.8% YoY Q1 Feb 2023
EPS Diluted (TTM)
—
Q1 Feb 2023
Gross Margin
—
Q1 Feb 2023
Operating Margin
—
Q1 Feb 2023
Net Margin
—
Q1 Feb 2023
Free Cash Flow (TTM)
−$74.54K
Q1 Feb 2023
Cash
$0
Q1 Feb 2023
Total Debt
$602.93K
Q1 Feb 2023
Shares Outstanding
78.36M sh
Q1 Feb 2023

Revenue & Net Income

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings